Rory B. Riggs - 27 May 2021 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role: Director
Signature: /s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol: ITCI
Transactions as of: 27 May 2021
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2021, 16:05:50 UTC
Previous filing: 28 May 2021
Next filing: 08 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITCI	Common Stock	Options Exercise		+13,767	+22%		75,708	27 May 2021	Direct	F1
holding	ITCI	Common Stock						226,670	27 May 2021	Held by New Ventures I, LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITCI	Restricted Stock Units	Options Exercise	$0	-13,767	-100%	$0.000000^*	0	27 May 2021	Common Stock	13,767		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock.
F2	Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.
F3	On May 27, 2020, the reporting person was granted 13,767 restricted stock units, vesting on the first anniversary of the grant date (May 27, 2021).